California Picks Generic Drug Company Civica to Produce Low-Cost Insulin

SACRAMENTO, Calif. — Gov. Gavin Newsom on Saturday announced the selection of Utah-based generic drug manufacturer Civica to produce low-cost insulin for California, an unprecedented move that makes good on his promise to put state government in direct competition with the brand-name drug companies that dominate the market. “People should not be forced to go into debt to get lifesaving prescriptions,” Newsom said. “Californians will have access to some of the most inexpensive insulin available, helping them save thousands of dollars each year.” The contract, with an initial cost of $50 million that Newsom and his fellow Democratic lawmakers appro...

Read the full post at Syndicate – Kaiser Health News